The journal Nature has published the results of a clinical trial led by researchers from the Clínica Universidad de Navarra…
UITM-CaixaResearch
Co-authored by investigators of VHIO’s Cancer Genomics Group and Research Unit for Molecular Therapy of Cancer (UITM) – CaixaResearch, results…
A new drug originally developed by Leukos Biotech S.L., a spin-off of the Josep Carreras Leukaemia Research Institute, in collaboration…
For many cancer patients, clinical trials are a new opportunity for treatment, especially in cases where various therapies have been…
Advances driven by research have led to significant developments in better understanding the molecular taxonomy of cancer and therapeutic breakthroughs…
Presented today at the ESMO Congress 2024* by Maria Vieito, Medical Oncologist at the Vall d’Hebron University Hospital, CORE Phase…
Initial data from the first phase 1 trial of the bispecific antibody FS222 demonstrate that it is a drug with…
Coinciding with the celebration on May 20 of the Clinical Trials World Day, this Monday the fifth chapter of the…
